Brenda Motheral

Brenda Motheral is the Co-Founder and CEO of Archimedes, a leading Specialty Drug Manager, providing cost management solutions for specialty drugs across pharmacy and medical benefits. Brenda co-founded and led EpiphanyRx LLC before it was acquired in 2021, and also founded Artemetrx, a consulting firm dedicated to specialty drug management. Previously, Brenda held positions at CareScientific and Express Scripts, where Brenda led research and product management. Brenda has a PhD in Health Economics from the University of South Carolina and an MBA from the University of Kentucky. Brenda is known for their expertise in pharmaceutical policy and management.